Breaking News

Tweet TWEET

Clovis Oncology to Announce First Quarter 2013 Financial Results and Host Webcast Conference Call on May 7

  Clovis Oncology to Announce First Quarter 2013 Financial Results and Host
  Webcast Conference Call on May 7

Business Wire

BOULDER, Colo. -- April 23, 2013

Clovis Oncology, Inc. (Nasdaq:CLVS) will announce its first quarter 2013
financial results on Tuesday, May 7, 2013, before the open of the U.S.
financial markets. Clovis’ senior management will host a conference call and
live audio webcast on Tuesday, May 7, at 8:30 a.m. ET to discuss the company’s
results in greater detail.

The conference call is being webcast and can be accessed from the Clovis
Oncology website at www.clovisoncology.com. A replay of the webcast will be
available for 30 days.

About Clovis Oncology

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring,
developing and commercializing innovative anti-cancer agents in the U.S.,
Europe and additional international markets. Clovis Oncology targets
development programs at specific subsets of cancer populations, and
simultaneously develops diagnostic tools that direct a compound in development
to the population that is most likely to benefit from its use. Clovis Oncology
is headquartered in Boulder, Colorado, and has additional offices in San
Francisco, California and Cambridge, UK.

Contact:

Clovis Oncology, Inc.
Anna Sussman, 303-625-5022
asussman@clovisoncology.com
or
Breanna Burkart, 303-625-5023
bburkart@clovisoncology.com
 
Press spacebar to pause and continue. Press esc to stop.